Leinender - Sight of the Unseen (Antisense remix) Video
Leinender - Sight of the Unseen (Antisense remix) [Techno]
Recent Police Force News:
Related Videos:
Global Dyslipidemia Therapeutics Market to Exceed $28 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of global report on Dyslipidemia Therapeutics market. The world market for Dyslipidemia Therapeutics is projected to exceed $28 billion by the year 2015. One of the key factors propelling the growth of anti-dyslipidemic drug market is aging population and the rising population of hypercholesterolemia patients.
Scientific and Business Leaders to Discuss Challenges Facing Developers of Pain Therapeutics at Arrowhead’s 4th Annual Pain Therapeutics Summit
Now in its 4th year, Arrowhead's Annual Pain Therapeutics Summit continues to attract both academic and industry leaders from around the globe to discuss pain management, preclinical and clinical development of new pain therapeutics.
Global Rheumatoid Arthritis Therapeutics Market to Exceed $23.12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Rheumatoid Arthritis Therapeutics markets. The world market for rheumatoid arthritis biologic therapeutics is projected to exceed $23.12 billion by 2015. The market comprises of a sizeable, growing patient population encompassing untreated patients, patients taking DMARDs, patients taking anti-TNF therapies, and patients taking non-anti-TNF therapies. Among all therapies, anti-pro-inflammatory drugs that block the action of TNF-alpha (known as anti-TNF biologics) dominate the market.
Global Non-Small Cell Lung Cancer Therapeutics Market to Reach $13.3 Billion by 2015, According to New Report by Global Industry Analysts
GIA announces the release of a comprehensive global report on Lung Cancer Therapeutics market. World market for non-small cell lung cancer therapeutics is expected to reach $13.3 billion by 2015 fueled by rising incidence of lung cancer, improved understanding of non-small cell lung cancer, and the development of new treatments targeted at growth factor pathways.
Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
The Drug Information Association (DIA), in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the 2nd Conference on Oligonucleotide-based Therapeutics (September 22 - 24; Falls Church, VA).
Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd. Under the agreement Dalton will continue to provide chemistry services in support of Boehringer's pharmaceutical development programs.
Arrowhead Publishers Releases New Report Analyzing the Global Cancer Therapy Market
A New report from Arrowhead Publishers entitled Cancer Therapeutics: Market Insight and R&D Pipeline Analysis provides valuable insight into the global market for cancer therapies and developmental-stage therapies.
Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligon
NittoPhase™ HL Loaded up to 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields
antisensedrugs.com
The antisense drug resource
adultstemcell.org
The adult stem cell forum
